On Sept. 24, Novo Nordisk CEO Lars Fruergaard Jørgensen is slated to testify at a Senate committee hearing about the costs for Wegovy and Ozempic.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
3 GLP-1 updates
On Sept. 24, Novo Nordisk CEO Lars Fruergaard Jørgensen is slated to testify at a Senate committee hearing about the costs for Wegovy and Ozempic.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis